Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
07/2009
07/21/2009CA2400261C Phenacylamine derivatives, process for their production and pesticides containing them
07/16/2009US20090181971 Inhibitors of Histone Deacetylase
07/15/2009CN101484415A Positively charged water-soluble prodrugs of aspirin
07/15/2009CN100513387C Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof
07/15/2009CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes
07/14/2009US7560589 Cycloalkylidene compounds as modulators of estrogen receptor
07/14/2009US7560582 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
07/14/2009US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable
07/14/2009US7560473 Amine derivative with potassium channel regulatory function, its preparation and use
07/14/2009US7560463 Diaryl ethers as opioid receptor antagonists
07/09/2009WO2009085562A1 Novel semi-synthetic glycopeptides as antibacterial agents
07/09/2009US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
07/09/2009US20090176853 Adamantane derivatives
07/09/2009CA2710602A1 Novel semi-synthetic glycopeptides as antibacterial agents
07/08/2009EP2077109A1 Amide compound, salt thereof, and biofilm remover using them
07/08/2009EP2076487A1 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives
07/08/2009CN101475509A Seaweed bromide phenol compounds containing acidamide or sulfone substituent, preparation and use thereof
07/08/2009CN100509783C Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
07/08/2009CN100509759C Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
07/07/2009US7557143 Such as 3,5-Dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl acetic acid; metabolism regulation agents; avoiding cardiovascular and other toxicities of hormones
07/07/2009CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
07/02/2009WO2009080769A1 Antitumoral compounds
07/02/2009WO2009079692A1 Halogenated analogues of anti-fibrotic agents
07/02/2009WO2009004642A3 PROCESS FOR MANUFACTURE OF HIGH PURITY D-(-)-N, N-DIETHYL-2-(α- NAPHTHOXY) PROPIONAMIDE
07/02/2009CA2715203A1 Antitumoral compounds
07/02/2009CA2709937A1 Halogenated analogues of anti-fibrotic agents
07/01/2009EP2075244A1 New route to building block for making renin inhibitors
07/01/2009EP1756043B1 Ortho substituted aryl or heteroaryl amide compounds
07/01/2009CN101472881A Benzylidene malonamide and salt thereof, ultraviolet ray absorbent, and agent for external application to the skin
07/01/2009CN100506786C Aspartate derivatives and process for their preparation
06/2009
06/30/2009US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma
06/30/2009US7553876 angiogenesis inhibitors; a salicylamides; amphiphilic compounds; used with various antiinflammatory and cytotoxic agents as well as with radio-therapeutic agents to treat tumor growth and metastasis
06/30/2009US7553872 Compounds and compositions for delivering active agents
06/30/2009US7553831 Beta-secretase inhibitors; inhibiting cleavage of amyloid precursor protein (APP); hydroxy-functional disubstituted amines such as 6-(([[(2S,3S)-4-(3,5-difluorophenyl)-3-((3-[(dipropylamino)carbonyl]benzoyl)amino)-2-hydroxybutyl](ethyl)amino]carbonyl)amino)hexanoic acid
06/30/2009US7553820 Mevalonic acid derivatives
06/30/2009US7553652 Polypeptide having amidohydrolase activity capable of hydrolysing 3,3,3-trifluoro-2-hydroxy-2-methyl propionamide in form of the racemate or of an optically active isomer; obtainable from Klebsiella oxytoca, Pseudomonas, Rhodococcus opacus, Arthrobacter ramosus, Bacillus
06/30/2009CA2406088C Novel phenyl-propargylether derivatives
06/25/2009WO2009079627A2 Reagents and methods for the beta-keto amide synthesis of a synthetic precursor to immunological adjuvant e6020
06/25/2009WO2009077387A1 2-fluoro-4-[(3,3,3-trifluoro-2-hydroxy-2-methylpropanoyl)amino]benzoate derivatives; compositions containing same; cosmetic uses
06/25/2009WO2009077385A1 Leukotriene b4 inhibitors
06/25/2009WO2009061744A3 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
06/25/2009WO2009051806A3 Modulation of nerve pain activity by resiniferatoxin and uses thereof
06/25/2009US20090163596 Bimatoprost crystalline form I
06/25/2009US20090163558 Substituted Methyl Aryl or Heteroaryl Amide Compounds
06/25/2009US20090163549 Pharmaceutical Composition Comprising an Amide Derivative
06/25/2009CA2708148A1 Reagents and methods for the beta-keto amide synthesis of a synthetic precursor to immunological adjuvant e6020
06/25/2009CA2707990A1 Leukotriene b4 inhibitors
06/24/2009EP1558567B1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds
06/24/2009EP1546090B1 Method for producing acylated peptides
06/23/2009US7550622 Cycloalkylamidoacid compounds, processes for making and uses thereof
06/23/2009US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
06/18/2009WO2009075557A1 Fluorobenzenamides having anti-convulsive activity
06/18/2009US20090156805 Cycloalkane Carboxamide Derivatives and Production Process of Same
06/17/2009EP2069355A1 Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity
06/17/2009EP2069288A1 TARTRATE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS
06/16/2009US7547802 Compounds for the treatment of metabolic disorders
06/16/2009CA2405136C Treatment of tumors with rar alpha selective retinoid compounds in combination with other anti-tumor agents
06/11/2009WO2009071957A2 Novel peptides and amino acid derivatives, pharmaceutical compositions containing same and the use of these compounds
06/11/2009WO2009027081A3 Process for preparing pentanoic diacid derivatives
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/10/2009EP2066619A2 Soluble epoxide hydrolase inhibitors
06/10/2009CN101454275A Orally bioavailable caffeic acid related anticancer drugs
06/10/2009CN101450915A Cyclohexene substituted benzoic acid derivates
06/10/2009CN101450914A Novel benzoic acid derivatives
06/10/2009CN101450913A Benzoic acid derivates containing phenyl cyclohexene
06/10/2009CN101450912A Tetrahydronaphthalene substituted benzoic acid derivates
06/10/2009CN101450911A Benzoic acid derivates substituted by adamantane
06/10/2009CN101450910A Branch-like rare-earth metal complexes
06/10/2009CN100497326C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics
06/09/2009US7544839 N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide; nervous system disorders; melatoninergic system disorders; industrial synthesis
06/09/2009US7544835 Carboxylic acid derivative and salt thereof
06/09/2009US7544717 2-amino- and 2-thio- substituted 1,3-diaminopropanes
06/09/2009US7544711 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents
06/09/2009US7544699 Aryl and heteroaryl compounds, compositions, and methods of use
06/09/2009US7544438 Quinone derivative; smooth charge transfer between electrode and enzyme biocatalyst; low cost, long term preformance; miniaturization; medical implants
06/04/2009US20090143374 Use of Compounds and Compositions for the Treatment of Amyloid Diseases
06/04/2009US20090143330 Crystalline Polymorphic Forms Of Monosodium N-[-8-(2-Hydroxybenzoyl)Amino]Caprylate
06/03/2009EP2065042A2 Antiparasitic composition containing an organic amine salt of closantel
06/03/2009EP2064199A1 Diaryl ether derivatives and uses thereof
06/03/2009EP2064175A1 A process for the manufacture of snac (salcaprozate sodium)
06/03/2009EP1487781B8 Process for preparing 2-aminoindan derivatives
06/03/2009CN101448782A 11beta-hydroxysteroid dehydrogenase type 1 active compounds
06/03/2009CN101444496A Compounds for the treatment of metabolic disorders
06/02/2009CA2116421C Inhibitors of hydroxyphenylpyruvate dioxygenase and an assay for identification of inhibitors
05/2009
05/28/2009US20090137845 Novel 4-Dedimethylaminotetracycline derivatives
05/28/2009US20090137834 Levodopa prodrugs, and compositions and uses thereof
05/27/2009EP2062875A1 New polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide
05/27/2009EP2061750A2 Improved process for synthesizing desvenlafaxine free base and salts or solvates thereof
05/27/2009EP1694627B1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
05/27/2009EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators
05/27/2009CN100491341C Separating and purifying method for N-methyl-2-(4-phenoxy phenoxy)-2-chloroacetamide
05/27/2009CN100491340C Method for preparing 2-{4-[[(3,5-dimethyl aniline) carbonyl] methyl] phenoxy} 2-methyl sodium propionate
05/26/2009US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression
05/26/2009US7538224 Such as 2,4-dihydroxy-6-(2-methoxyethyl)phenylphenylketone; antitumor activity; heat shock protein (Hsp) suppression
05/26/2009US7538141 N-benzyl-2-{3-[2-({2-hydroxy-2-[5-hydroxy-6-(hydroxymethyl)pyridin-2-yl]ethyl}amino)-2-methylpropyl]phenyl}acetamide; beta 2 adrenergic receptors agonist; antiinflammatory, antiallergent, respiratory system disorder; side effect reduction; pharmacokinetics, potency, selectivity, duration of action
05/26/2009CA2411754C 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
05/26/2009CA2344058C Diaminopropionic acid derivatives
05/22/2009WO2009062949A1 New polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide
05/22/2009WO2009034432A3 Novel compounds active as muscarinic receptor antagonists
05/22/2009WO2007095584A3 Histone Deacetylase Inhibitors
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 157